Stem cell therapy: a promising solution for type 2 diabetes in Pakistan
DOI:
https://doi.org/10.18203/issn.2454-2156.IntJSciRep20243809Keywords:
Stem cell therapy, Type 2 DM, Type 2 diabetes mellitus, Diabetes mellitusAbstract
The World Health Organization (WHO) has reported that non-communicable diseases (NCDs) are responsible for 58% of deaths in the Pakistani community. Diabetes mellitus being among the top four NCDS contributing to the stated percentage. It has been stated that 16.98% of Pakistan's population has fallen victim to type II diabetes mellitus, hence demanding the need for effective and innovative measures.
Metrics
References
World Health Organization. Noncommunicable diseases Pakistan 2018 country profile. Available at: https://cdn.who.int/media/docs/default-source/ country-profiles/ncds/pak_en.pdf?sfvrsn=365b2b11 _39&download=true. Accessed on 12 October 2024.
Aamir AH, Ul-Haq Z, Mahar SA, Qureshi FM, Ahmad I, Jawa A, et al. Diabetes Prevalence Survey of Pakistan (DPS-PAK): prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: a population-based survey from Pakistan. BMJ Open. 2019;9(2):e025300. DOI: https://doi.org/10.1136/bmjopen-2018-025300
World Health Organization. Diabetes. Available at: https://www.who.int/news-room/fact-sheets/detail/ diabetes. Accessed on 12 October 2024.
Izadi M, Sadr Hashemi Nejad A, Moazenchi M, Masoumi S, Rabbani A, Kompani F, et al. Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial. Stem Cell Res Ther. 2022;13(1). DOI: https://doi.org/10.1186/s13287-022-02941-w
Downloads
Published
How to Cite
Issue
Section
